Cargando…
A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study
Neoadjuvant therapy (NAT) is a major treatment option for locally advanced rectal cancer. With recent advancement of machine/deep learning algorithms, predicting the treatment response of NAT has become possible using radiological and/or pathological images. However, programs reported thus far are l...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269576/ https://www.ncbi.nlm.nih.gov/pubmed/37334122 http://dx.doi.org/10.7717/peerj.15408 |
_version_ | 1785059200759496704 |
---|---|
author | Wu, Yihan Liu, Xiaohua Liu, Fang Li, Yi Xiong, Xiaomin Sun, Hao Lin, Bo Li, Yu Xu, Bo |
author_facet | Wu, Yihan Liu, Xiaohua Liu, Fang Li, Yi Xiong, Xiaomin Sun, Hao Lin, Bo Li, Yu Xu, Bo |
author_sort | Wu, Yihan |
collection | PubMed |
description | Neoadjuvant therapy (NAT) is a major treatment option for locally advanced rectal cancer. With recent advancement of machine/deep learning algorithms, predicting the treatment response of NAT has become possible using radiological and/or pathological images. However, programs reported thus far are limited to binary classifications, and they can only distinguish the pathological complete response (pCR). In the clinical setting, the pathological NAT responses are classified as four classes: (TRG0-3), with 0 as pCR, 1 as moderate response, 2 as minimal response and 3 as poor response. Therefore, the actual clinical need for risk stratification remains unmet. By using ResNet (Residual Neural Network), we developed a multi-class classifier based on Hematoxylin-Eosin (HE) images to divide the response to three groups (TRG0, TRG1/2, and TRG3). Overall, the model achieved the AUC 0.97 at 40× magnification and AUC 0.89 at 10× magnification. For TRG0, the model under 40× magnification achieved a precision of 0.67, a sensitivity of 0.67, and a specificity of 0.95. For TRG1/2, a precision of 0.92, a sensitivity of 0.86, and a specificity of 0.89 were achieved. For TRG3, the model obtained a precision of 0.71, a sensitivity of 0.83, and a specificity of 0.88. To find the relationship between the treatment response and pathological images, we constructed a visual heat map of tiles using Class Activation Mapping (CAM). Notably, we found that tumor nuclei and tumor-infiltrating lymphocytes appeared to be potential features of the algorithm. Taken together, this multi-class classifier represents the first of its kind to predict different NAT responses in rectal cancer. |
format | Online Article Text |
id | pubmed-10269576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102695762023-06-16 A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study Wu, Yihan Liu, Xiaohua Liu, Fang Li, Yi Xiong, Xiaomin Sun, Hao Lin, Bo Li, Yu Xu, Bo PeerJ Computational Biology Neoadjuvant therapy (NAT) is a major treatment option for locally advanced rectal cancer. With recent advancement of machine/deep learning algorithms, predicting the treatment response of NAT has become possible using radiological and/or pathological images. However, programs reported thus far are limited to binary classifications, and they can only distinguish the pathological complete response (pCR). In the clinical setting, the pathological NAT responses are classified as four classes: (TRG0-3), with 0 as pCR, 1 as moderate response, 2 as minimal response and 3 as poor response. Therefore, the actual clinical need for risk stratification remains unmet. By using ResNet (Residual Neural Network), we developed a multi-class classifier based on Hematoxylin-Eosin (HE) images to divide the response to three groups (TRG0, TRG1/2, and TRG3). Overall, the model achieved the AUC 0.97 at 40× magnification and AUC 0.89 at 10× magnification. For TRG0, the model under 40× magnification achieved a precision of 0.67, a sensitivity of 0.67, and a specificity of 0.95. For TRG1/2, a precision of 0.92, a sensitivity of 0.86, and a specificity of 0.89 were achieved. For TRG3, the model obtained a precision of 0.71, a sensitivity of 0.83, and a specificity of 0.88. To find the relationship between the treatment response and pathological images, we constructed a visual heat map of tiles using Class Activation Mapping (CAM). Notably, we found that tumor nuclei and tumor-infiltrating lymphocytes appeared to be potential features of the algorithm. Taken together, this multi-class classifier represents the first of its kind to predict different NAT responses in rectal cancer. PeerJ Inc. 2023-06-12 /pmc/articles/PMC10269576/ /pubmed/37334122 http://dx.doi.org/10.7717/peerj.15408 Text en ©2023 Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Computational Biology Wu, Yihan Liu, Xiaohua Liu, Fang Li, Yi Xiong, Xiaomin Sun, Hao Lin, Bo Li, Yu Xu, Bo A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title | A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title_full | A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title_fullStr | A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title_full_unstemmed | A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title_short | A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
title_sort | multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study |
topic | Computational Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269576/ https://www.ncbi.nlm.nih.gov/pubmed/37334122 http://dx.doi.org/10.7717/peerj.15408 |
work_keys_str_mv | AT wuyihan amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liuxiaohua amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liufang amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liyi amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT xiongxiaomin amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT sunhao amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT linbo amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liyu amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT xubo amulticlassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT wuyihan multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liuxiaohua multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liufang multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liyi multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT xiongxiaomin multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT sunhao multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT linbo multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT liyu multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy AT xubo multiclassclassificationalgorithmbasedonhematoxylineosinstainingforneoadjuvanttherapyinrectalcanceraretrospectivestudy |